ONXX Related StreetInsider.com Reports
-
StreetInsider.com Pre-Open Movers 5/8: (ALXA) (LEDR) (WBMD) Higher; (FIO) (OCLR) (VCLK) Lower (more...)
-
Streetinsider.com After-Hours Movers 05/07: (WBMD) (WFM) (EA) Higher; (OCLR) (SYNC) (VCLK) Lower (more...)
-
Onyx Pharmaceuticals, Inc. (ONXX) Reports Much Smaller Q1 Loss
-
Trading Radar for 05/07: Electronic Arts (EA), DirecTV (DTV), Fossil (FOSL), McKesson (MCK) Report
-
Bayer, Onyx (ONXX) Receive Approval in Japan Stivarga as mCRC Treatment
-
Jefferies Lifts PT on Onyx Pharmaceuticals (ONXX) to $104
-
Jefferies Positive on Onyx Pharmaceuticals (ONXX) after NCCN Compendia Listing For Frontline Kyprolis
-
Jefferies Trims PT on Onyx Pharmaceuticals (ONXX) Post Q4
-
Onyx Pharmaceuticals, Inc. (ONXX) Posts Q4 Loss of $0.36/Sh
-
Trading Radar for 02/21: Wal-mart (WMT), AIG (AIG), H-P (HPQ), Chesapeake (CHK), Safeway (SWY) Report
-
Onyx (ONXX) Reports Publication of Kyprolis Phase 2 Data
-
JMP Securities Starts Onyx Pharmaceuticals (ONXX) at Market Outperform
-
Approval of Celgene's (CELG) Pomalyst Largely Expected by Street (ONXX)
-
Onyx Pharma (ONXX) Prices 4.4M Offering; Sees Proceeds of $359M
-
Onyx Pharmaceuticals (ONXX) Announces 4.4M Offering
-
Onyx (ONXX) Updates on FY12 Ops, Achievements; Plans Kyprolis Phase 3 in FY13
-
Onyx Pharma's (ONXX) Kyprolis 'Killin It'
-
UBS Starts Onyx Pharmaceuticals (ONXX) at Buy
-
Onyx Pharmaceuticals (ONXX) May Have Untapped Opportunity in Frontline Multiple Myeloma
-
Pure Bioscience, Inc. (PURE) Reports Q1 Loss of $0.25
-
Dawson James Starts Onyx Pharmaceuticals (ONXX) at Market Outperform
-
Diamondback's Top Holdings into Liquidation (AAPL) (SPY) YHOO) (JPM)
-
Baird Slaps $99 Price Target on Onyx Pharmaceuticals (ONXX)
-
Onyx Pharmaceuticals, Inc. (ONXX) Tops Q3 EPS by 11c
-
Trading Radar for 11/01: Sirius XM (SIRI), Pfizer (PFE), Las Vegas Sands (LVS), priceline.com (PCLN), Chesapeake (CHK), Avon (AVP) Report
-
Onyx Pharma (ONXX) Completes Enrollment in Carfilzomib Phase 3
-
Notable Analyst Rating Changes 10/11: (NYT) (BANR) (LEAP) Upgraded; (MAR) (ONE) (PCS) Downgraded
-
UPDATE: Canaccord Genuity Assumes Onyx Pharmaceuticals (ONXX) at Buy
-
Streetinsider.com's Hot Lunchtime Reads 09/27: (ONXX) (DELL) (SPLS) (AAMRQ)
-
Onyx (ONXX), Bayer Win Early Approval for Colorectal Cancer Treatment
-
Brean Murray Carret & Co. Assumes Onyx Pharmaceuticals (ONXX) at Buy, Kyprolis is Key
-
Baird Reiterates an 'Outperform' on Onyx Pharmaceuticals (ONXX); Raising Kyprolis Estimates
-
Bayer Submits Application for Drug to Treat Gastrointestinal Stromal Tumors (ONXX)
-
Onyx's (ONXX) Myeloma Drug Might be used for Earlier Stage Treatments
-
Jefferies Reiterates a 'Buy' on Onyx Pharmaceuticals (ONXX); Predicting Strong Kyprolis Launch
-
Onyx Pharmaceuticals (ONXX) Is Trading at Pre-Kyprolis Approval Levels; Is It Time to Buy?
-
Griffin Securities Reiterates a 'Buy' on Ligand Pharma (LGND); Investors Jumped The Gun...Attractive Opportunity
-
Baird Reiterates an 'Outperform' on Onyx Pharmaceuticals (ONXX); Kyprolis Uptake and Take-out Potential
-
Onyx Pharmaceuticals, Inc. (ONXX) Posts Wider than Expected Q2 Loss of 68c/Share
-
Trading Radar for 08/01: MasterCard (MA), Green Mountain (GMCR), Time Warner (TWX), Comcast (CMCSA), MetLife (MET), Avon (AVP)Report
-
Streetinsider.com's Hot Lunchtime Reads 07/23: (GM) (TXN) (JCP) (BAC) (BKS) (ONXX)
-
Notable Analyst Rating Changes 07/23: (MDC) (ONXX) (BYD) Upgraded; (MAR) (VRSN) (WAG) Downgraded
-
Baird Reiterates an 'Outperform' on Onyx Pharmaceuticals (ONXX); FDA approval of Kyprolis and Increased Takeover Chatter
-
Bernstein Downgrades Onyx Pharma (ONXX) to Market Perform
-
Cantor Fitzgerald Maintains a 'Buy' on Ligand Pharma (LGND); Key Partnered Drug is Approved
-
Deutsche Bank Maintains a 'Buy' on Onyx Pharmaceuticals (ONXX); SEARCH Fails, But Success Wasn't Necessary
-
Jefferies Upgrades Onyx Pharmaceuticals (ONXX) to Buy; FDA Approves Kyprolis; Takeover Speculation Intensifies
-
Bayer, Astellas, Onyx Pharma (ONXX) Report Negative Outcome in Tarceva Phase 3 Safety, Efficacy Trial
-
Notable 52-Week Highs and Lows of the Day 07/20: (ONXX) (EBAY) (PSTI) High; (AMD) (ETFC) (TSU) Low
-
Barclays Upgrades Onyx Pharmaceuticals (ONXX) to Overweight
Back to ONXX Stock Lookup
